| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 155,164 | 130,341 | 167,953 | 207,397 | | Cost of Revenue | 52,634 | 71,786 | 27,594 | 53,695 | | | Gross Profit | 102,530 | 58,555 | 140,359 | 153,702 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,130 | (18,496) | 28,720 | 4,010 | | Non Recurring |
-
|
-
| 1,037,000 |
-
| | Others | 46,367 | 44,974 | 60,661 | 54,114 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 51,033 | 32,077 | (986,022) | 95,578 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (55,237) | (61,202) | 203,815 | 14,418 | | Earnings Before Interest And Taxes | (4,204) | (29,125) | (782,207) | 109,996 | | Interest Expense | 9,743 | 9,898 | 7,297 | 6,279 | | Income Before Tax | (13,947) | (39,023) | (789,504) | 103,717 | | Income Tax Expense | (5,616) | (13,497) | (276,916) | 38,624 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,331) | (25,526) | (512,588) | 65,093 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,331) | (25,526) | (512,588) | 65,093 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| (887,820) | | | Net Income Applicable To Common Shares | ($8,331) | ($25,526) | ($512,588) | ($822,727) |
|
0.11% Nasdaq 
0.01%
Income Statement
